CAR-T cell therapy
Review CAR-T cell therapy questions for China, including product authorisation, clinical eligibility and specialist monitoring. Benefit is not guaranteed.
Illustrative external reference (USD): $120,000 to $200,000. Not a SeekDoctor offer or a confirmed hospital fee.
Eligibility and evidence
Ask for the exact product, current authorisation in China and approved indication, or registered trial and ethics approval if investigational. Evidence for selected blood cancers must not be generalised to solid tumours. Cytokine release syndrome and neurological toxicity require specialist monitoring; benefit is not guaranteed. SeekDoctor coordinates enquiries and visits. Hospitals and licensed clinicians make clinical decisions.